What question did this study set out to answer?

To evaluate the risk and pathology underlying drug-induced tubulointerstitial nephritis in clinical settings.

March 27, 2026Open Access

WCN26-4895 Real-World Risk of Drug-Induced Tubulointerstitial Nephritis

JWJ WangTianjin University of Traditional Chinese Medicine

Puntos clave

To evaluate the risk and pathology underlying drug-induced tubulointerstitial nephritis in clinical settings.
Analysis of real-world clinical data on drug-induced kidney injuries.
Classification of nephritis types based on pathogenesis and drug exposure.
Review of medical records to identify cases of tubulointerstitial nephritis.
Tubulointerstitial nephritis is a common subtype of drug-induced kidney injury.
Identified both cytotoxic and immune-mediated mechanisms in the pathology of TIN.
Certain drugs were correlated with increased incidence of nephritis symptoms.

Resumen

Drug-induced drug-induced kidney injury (DIKI) represents a prevalent challenge in clinical practice and novel drug development, with diverse pathological manifestations affecting multiple renal components, including glomeruli, renal vasculature, tubules, and interstitium. Among various forms of DIKI, tubulointerstitial nephritis (TIN) stands as a critical and common pathological subtype. Its pathogenesis is complex, primarily categorized into two types: direct cytotoxic damage to renal tubular epithelial cells by drugs or their metabolites, and immune-mediated hypersensitivity reactions triggered by the host response to drugs.

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

J Wang (Wed,) studied this question.

synapsesocial.com/papers/69c620d515a0a509bde19805 https://doi.org/https://doi.org/10.1016/j.ekir.2026.103979

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo